Trinity Biotech (TRIB) EBITDA (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly EBITDA of -$11.5 million for Q4 2024, down 204.66% year-on-year from $11.0 million in Q1 2024, and down 350.08% on a QoQ basis from -$2.6 million in Q3 2024.
Trinity Biotech (TRIB) EBITDA (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported EBITDA for 16 consecutive years, with -$11.5 million the latest figure, recorded in Q4 2024.
- Quarterly EBITDA fell 204.66% year-over-year to -$11.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$21.2 million (up 21.76% YoY) and the FY2025 annual result came in at -$15.8 million, up 25.4% from the prior year.
- EBITDA declined to -$11.5 million in Q4 2024 per TRIB's latest filing, from -$2.6 million in the prior quarter.
- Over the last five years, EBITDA for TRIB reached as high as $9.1 million in Q3 2020 and fell as low as -$14.9 million in Q2 2023.
- A 5-year average of -$2.0 million and a median of -$2.2 million in 2022 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2020 — EBITDA jumped 581.55% — and 2022, when it tumbled 1548.85%.
- Year by year, EBITDA stood at $9.1 million in 2020, then tumbled by 93.79% to $563000.0 in 2021, then slumped by 1548.85% to -$8.2 million in 2022, then surged by 53.67% to -$3.8 million in 2023, then plunged by 204.66% to -$11.5 million in 2024.
- According to Business Quant data, EBITDA over the past three periods registered -$11.5 million, -$2.6 million, and -$4.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -11.51 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -4.05 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | -3.78 Mn |
| Sep 30, 2023 | -4.50 Mn |
| Jun 30, 2023 | -14.85 Mn |
| Mar 31, 2023 | -3.92 Mn |
| Dec 31, 2022 | -8.16 Mn |
| Sep 30, 2022 | -8.13 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | 563,000.00 |
| Sep 30, 2021 | 2.77 Mn |
| Jun 30, 2021 | 218,000.00 |
| Mar 31, 2021 | 3.08 Mn |
| Dec 31, 2020 | 9.07 Mn |
| Sep 30, 2020 | 9.09 Mn |
| Jun 30, 2020 | 501,000.00 |
| Mar 31, 2020 | 1.69 Mn |